Latest News
News
Herpes zoster risk increased with some psoriasis, psoriatic arthritis treatments
Patients with psoriasis and psoriatic arthritis may be at an increased risk of herpes zoster, particularly those treated with tofacitinib or...
News
FDA approves patient-controlled injector for guselkumab
The Food and Drug Administration has
News
Golimumab plus methotrexate looks good in early psoriatic arthritis
Rates of DAS remission were 81% versus 42% with methotrexate monotherapy.
News
FDA: Safety signal emerged with higher dose of tofacitinib in RA study
The FDA is working with Pfizer to better understand how the signal affects patients and how the drug should be used, the agency said in a...
Conference Coverage
Ixekizumab psoriasis outcomes, sliced and diced
WAIKOLOA, HAWAII – The jaw-dropping NNT to achieve complete skin clearance: 2.6 patients.
News
AAD, NPF release two joint guidelines on treatment, management of psoriasis
The next guidelines will address phototherapy, topical therapy, nonbiologic systemic medications, and treatment of pediatric patients.
Conference Coverage
What’s new with adalimumab? Plenty
WAIKOLOA, HAWAII – New information includes reassuring new long-term, real-world safety data, plus a simple early predictor of PASI 75 response....
News
Biologics curb coronary artery plaques in severe psoriasis
Treating psoriasis with biologics improves coronary plaque profiles, suggesting an impact on inflammation and opportunity to reduce cardiovascular...
News
Different disease features found with family history of psoriasis versus PsA
The finding suggests different genetic backgrounds and pathogenic mechanisms in these subsets.
News
Psoriatic arthritis eludes early diagnosis
Patients with psoriasis have an increased risk for psoriatic arthritis, but diagnosing its onset early poses challenges.